Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00578838 · ClinicalTrials.gov registry record

Magnetic Resonance Study of Liver in Chemotherapy

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
55
Enrollment target

NCT00578838: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00578838 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00578838 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
55 participants
Enrollment target

Study Summary

The purpose of this study is to see whether magnetic resonance (MR) techniques can detect changes caused by chemotherapy in the livers of patients who have been treated for colorectal cancer. Some patients who undergo chemotherapy for colorectal cancer may experience side-effects in their livers. These side effects may influence further treatment options. If this study finds that MR techniques detect changes in the liver due to chemotherapy, then MR methods may eventually be used to help patients and physicians plan further treatment.

Interventions

  • OTHER Magnetic Resonance

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2006-08
Est. Completion 2016-05

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00578838

The ClinicalTrials.gov registry entry for NCT00578838 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance is the first listed.

NCT00578838 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00578838 about?

NCT00578838 is a clinical study titled "Magnetic Resonance Study of Liver in Chemotherapy". The purpose of this study is to see whether magnetic resonance (MR) techniques can detect changes caused by chemotherapy in the livers of patients who have been treated for colorectal cancer. Some patients who undergo chemotherapy for colorectal cancer may experience side-effects in their livers. Th...

What is the current status of trial NCT00578838?

This trial is currently completed. The enrollment target is 55 participants. The study started on 2006-08. Estimated completion is 2016-05.

What interventions are being tested in trial NCT00578838?

The interventions under investigation include: Magnetic Resonance (OTHER).

Who is sponsoring clinical trial NCT00578838?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.